Cancer Biology

Discussions of New Developments and Updates

Home
About
Topics
SHU Department of Biology

Tag Archives: gene editing

Cell-based Immunotherapies in the News

Baxalta, the biopharmaceutical spinoff of Baxter, entered into a $1.7 B deal with Precision BioSceinces for 6 CAR-T (Chimeric Antigen Receptor T-cell) projects, and Saronic Biotechnology announced positive data in preclinical studies of its autologous dendritic cell vaccine for hepatocellular carcinoma. Continue reading →

This entry was posted in CAR-T, Dendritic cells, Immunology & Immunotherapy, Uncategorized, Vaccines and tagged ARCUS, Baxalta, CAR-T, Cellectis, dendritic cells, FOXP3, gene editing, homing endonuclease, immunotherapy, Juno, Kite, Novartis, Pfizer, Precision BioSciences, Saronic Biotechnology, Treg on March 2, 2016 by Joseph Gulfo.

Gene-edited donor T-cells save baby with incurable leukemia

An experimental therapy made of genetically-modified donor T-cells cured a baby with incurable leukemia: Continue reading →

This entry was posted in CAR-T, Immunology & Immunotherapy, passive immunotherapy, Uncategorized and tagged CAR T-cells, Cellectis, Chimeric Antigen Receptor T-cells, deoxycitidine kinase, fludarabine, gene editing, Leukemia, TALEN, transcription activator like effectors on November 11, 2015 by Joseph Gulfo.

Search for:

This blog is designed to provide updates in developments in cancer biology and engage in discussions about new findings in the field.

Sponsored by the Department of Biology, Seton Hall University.

@josephgulfo

[fts_twitter twitter_name=@josephgulfo tweets_count=6 cover_photo=no stats_bar=no show_retweets=no show_replies=no]

Proudly powered by WordPress

Pin It on Pinterest